Detalles de la búsqueda
1.
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Ann Hematol
; 103(2): 427-436, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012435
2.
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation.
Eur J Haematol
; 112(6): 938-943, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332702
3.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354090
4.
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Expert Opin Emerg Drugs
; 28(3): 153-165, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256917
5.
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors.
Curr Opin Oncol
; 34(6): 729-737, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017560
6.
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
Ann Hematol
; 101(6): 1275-1282, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318505
7.
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters.
Br J Haematol
; 193(1): 129-132, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808672
8.
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.
Ann Hematol
; 100(5): 1213-1219, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677654
9.
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
Ann Hematol
; 100(8): 2005-2014, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388860
10.
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.
Acta Oncol
; 60(11): 1520-1526, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461798
11.
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience.
Ann Hematol
; 99(10): 2405-2416, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32813071
12.
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients.
Ann Hematol
; 99(12): 2773-2777, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32462330
13.
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
Ann Hematol
; 99(7): 1525-1530, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474619
14.
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Eur J Haematol
; 105(3): 286-291, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365249
15.
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
Hematol Oncol
; 37(3): 296-302, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892724
16.
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice.
Ann Hematol
; 98(8): 1919-1925, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31168652
17.
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life.
Ann Hematol
; 98(8): 1891-1904, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079264
18.
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.
Ann Hematol
; 98(8): 1933-1936, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31201513
19.
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Eur J Haematol
; 112(4): 654-657, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093665
20.
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.
Ann Hematol
; 97(10): 1803-1808, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806063